Genomma Lab’s $126 Million Notes Offering


Creel, García-Cuéllar, Aiza y Enríquez advised on the transaction

Genomma Lab executed a $126 Million Notes Offering in Mexico.

BBVA Bancomer Casa de Bolsa, Santander Casa de Bolsa and Actinver Casa de Bolsa acted as Underwriters on the offering

Genomma Lab Internacional SAB de CV develops, markets, sells and distributes over-the-counter drugs and personal care products. The company, led by Maximo Juda, Antonio Zamora Galland and Marco Sparvieri, in 2017 recorded $620 Million Revenues.

Creel, García-Cuéllar, Aiza y Enríquez, advised Genomma Lab with Carlos Zamarrón (Picture) Jorge Escalante and Patricia Ramírez.

Involved fees earner: Carlos Zamarrón – Creel, García-Cuéllar, Aiza y Enriquez SC; Jorge Escalante Zollino – Creel, García-Cuéllar, Aiza y Enriquez SC; Patricia Ramírez Sanchez – Creel, García-Cuéllar, Aiza y Enriquez SC;

Law Firms: Creel, García-Cuéllar, Aiza y Enriquez SC;

Clients: Genomma Lab Internacional SAB de CV;

Avatar

Author: Ambrogio Visconti.